Company intelligence / Profile preview

Austin Davis Biologics

Kettering, Northamptonshire, United Kingdomaustindavis.co.uk ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Austin Davis Biologics has commercialized the EquiSal® Tapeworm saliva test and blood ELISA for diagnosing equine tapeworm infections. The company also offers a Small Redworm Blood Test and continues to develop additional equine health diagnostic products. Their tests are used by veterinary practices and laboratories internationally.

Therapeutic areas: Infectious Diseases
Modalities: Protein (ELISA-based diagnostics)Device (saliva collection swabs)Diagnostic test kit
Industry: Veterinary

Partnerships

Moredun Research Institute (co-development of the Small Redworm Blood Test)

Beyond the preview

Go deeper on Austin Davis Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Austin Davis Biologics.

Explore the full profile